Concepedia

Author

Heather Giles

Wellcome Trust

Also Known As

H Giles, H. G. GILES, H. G. Giles, H. GILES, H. GWYNNE GILES, H. Giles, H. Gwynne Giles, H.G. Giles, Hardingham Giles, Heather Giles

60

Publications

2.1K

Citations

24

H-Index

62

Concepts

All Affiliations

Wellcome TrustGlaxoSmithKline (United Kingdom)GlaxoSmithKline (India)University College LondonUniversity of Warwick
HG

About

Heather Giles is an author at Wellcome Trust specializing in pharmacology, medicine, and physiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

14

15

972

2

Engineering

5

5

146

3

Natural Sciences

4

4

87

4

Health Sciences

1

1

29

5

Anesthesia

1

1

101

Heather Giles

×

34

Publications

1.8K

Citations

24

H-Index

YearCitations

Platelet glycoprotein IIb‐IIIa and size are increased in acute myocardial infarction

Heather Giles, Russell E.A. Smith, John F. Martin

European Journal of Clinical Investigation

1994

213

The classification of prostaglandin DP‐receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist

Heather Giles, P. Leff, Mary L. Bolofo,

British Journal of Pharmacology

1989

195

Effects of acute and chronic administration of β-adrenoceptor ligands on airway function in a murine model of asthma

Zsuzsanna Callaerts‐Vegh, Kenda L. J. Evans, Noornabi Dudekula,

Proceedings of the National Academy of Sciences

2004

145

Pharmacological characterization of human recombinant melatonin mt<sub>1</sub> and MT<sub>2</sub> receptors

Christopher R. Browning, I.J.M. Beresford, Neil J. Fraser,

British Journal of Pharmacology

2000

132

Receptor specificity and trigemino‐vascular inhibitory actions of a novel 5‐HT<sub>1B/1D</sub> receptor partial agonist, 311C90 (zolmitriptan)

Graeme R. Martin, Alan D. Robertson, Sara MacLennan,

British Journal of Pharmacology

1997

101

Estimation of agonist affinity and efficacy by direct, operational model-fitting

P. Leff, D.J. Prentice, Heather Giles,

Journal of Pharmacological Methods

1990

89

GW627368X ((<i>N</i>‐{2‐[4‐(4,9‐diethoxy‐1‐oxo‐1,3‐dihydro‐2<i>H</i>‐benzo[<i>f</i>]isoindol‐2‐yl)phenyl]acetyl} benzene sulphonamide): a novel, potent and selective prostanoid EP<sub>4</sub> receptor antagonist

Richard J. Wilson, Gerard M.P. Giblin, Susan Roomans,

British Journal of Pharmacology

2006

78

Signalling by CXC‐chemokine receptors 1 and 2 expressed in CHO cells: a comparison of calcium mobilization, inhibition of adenylyl cyclase and stimulation of GTPγS binding induced by IL‐8 and GRO<i>α</i>

David A. Hall, I.J.M. Beresford, Christopher R. Browning,

British Journal of Pharmacology

1999

74

Inhibition of endothelium‐dependent vasorelaxation by arginine analogues: a pharmacological analysis of agonist and tissue dependence

Graeme R. Martin, Mary L. Bolofo, Heather Giles

British Journal of Pharmacology

1992

70

Characterization of a 5‐HT<sub>1B</sub> receptor on CHO cells: functional responses in the absence of radioligand binding

Heather Giles, Stuart J. Lansdell, Mary L. Bolofo,

British Journal of Pharmacology

1996

64

Page 1